PulmonIx has conducted Phase Ib to Phase 4 clinical trials for a variety of indications but has special interest and expertise in Interstitial Lung Disease (ILD) trials and is recognized as a designated center for the Pulmonary Fibrosis Foundation (PFF) care center network (CCN). Work from PulmonIx has contributed to several cutting edge publications. Though PulmonIx is currently only involved in Pulmonary Fibrosis related trials, the wide range of indications we have been involved in is listed below:
- COPD
- Asthma
- Interstitial Lung Disease
- Bronchiectasis
- Pulmonary Hypertension
- Sepsis
- ARDS
- Delirium
- Lung Cancer Diagnosis
- Inpatient internal medicine trials (pneumonia, delirium, nutrition etc.)
Please contact us to learn more.
Why Participate?
Clinical trials study whether or not new medicines, devices, or diagnostic techniques work and are safe for use. Patients choose to participate in clinical trials for a variety of reasons such as a desire to contribute to the greater good through science or access to cutting-edge treatments. By participating in clinical trials they are frequently seen by highly trained experts in their field. Compensation for time and effort is sometimes offered for trial participation. Clinical trials are carefully planned and meticulously reviewed by groups of health specialists called Institutional Review Boards. Patients participate exclusively as volunteers for studies and enroll only after a detailed informed consent process. Patient volunteers have the right to drop out of a trial at any time.
Want more information? Please take a look at our educational resources page.
Current Trials
Clinical Trials for Patients with Idiopathic Pulmonary Fibrosis
Celea Therapeutics (SURPASS-IPF)
- Sponsor website: https://www.celeatx.com
- Study Details: https://clinicaltrials.gov/study/NCT07284602
United Therapeutics, Corp. (TETON 302) – Open Label Extension
- Sponsor website: https://www.unither.com/home
- Study Details: https://clinicaltrials.gov/study/NCT04905693
Clinical Trials for Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
Pulmovant, Inc. (PHactor RVT-2301-202)
- Sponsor website: https://pulmovant.com/
- Study Details: https://clinicaltrials.gov/study/NCT07333183
Non-interventional Clinical Studies (Registries) for Patients with IPF/ILD
Boehringer Ingelheim (IPF-ILD-Pro Registry)
- Sponsor website: https://www.boehringer-ingelheim.com/
- Study Details: https://clinicaltrials.gov/study/NCT01915511
Non-interventional Clinical Studies (Registries) for Patients with PH-ILD
United Therapeutics, Corp. (DeciPHer-ILD Registry)
- Sponsor website: https://pipeline.unither.com/
- Study Details: https://clinicaltrials.gov/study/NCT06388421
Non-interventional Clinical Studies (Registries) for Patients with Lung Nodules
Freenome Holdings, Inc. (FRNM-009)
- Sponsor website: https://www.freenome.com/
Non-interventional Clinical Studies (Registries) for Patients with Chronic Obstructive Pulmonary Disease
GSK (REALITI-C COPD Study)
- Sponsor website: https://www.gsk.com/
- Study Details: https://www.gsk-studyregister.com/trials/223598
Trial Finders (3rd party links)
*PulmonIx does not endorse these trials, they are provided for user convenience
https://trials.pulmonaryfibrosis.org/
Pulmonary Fibrosis Foundation trial finder for patients with all types of pulmonary fibrosis.